Vertex Pharmaceuticals Incorporated
VRTX stock score: 65/100
$524.52 · +1.92% · Scored Oct 21, 2026
- Technical
- 66
- Fundamental
- 63
- News
- 57
The reading
Vertex Pharmaceuticals (VRTX) scores 65 out of 100, which reads neutral, higher than 93% of Healthcare stocks and 88% of the 4,166 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 66, fundamentals 63.
Among the fundamentals, Earnings Growth (Annual) at 100 and Revenue Quality (Quarterly) at 100 score highest, while Fair Value at 0 weighs the most against it.
On the daily chart, trend-following indicators average 64 and contrarian oscillators 45.
News sentiment is neutral at 57; it is shown, not counted in the composite.
Since Jul 24, 2026 the composite has ranged from 59 to 76, and it is down 11 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward VRTX’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
63Pulling it up
- Earnings Growth (Annual)100
Annual earnings growth tracks year-over-year profit expansion.
- Revenue Quality (Quarterly)100
Revenue Quality (Quarterly) evaluates recent revenue performance using trailing 12-month data from quarterly reports.
- Operating Margins98
Operating margins measure profitability after operating expenses.
Holding it back
- Fair Value0
Fair value score synthesizes multiple valuation methods (DCF, P/E, P/B, P/S) to estimate intrinsic worth.
- Price to Sales Ratio11
Price-to-Sales ratio compares market capitalization to annual revenue.
- Price to Book Ratio18
Price-to-Book ratio compares market value to book value.
41 weighted scorers.
Technical · daily
62Pulling it up
- Parabolic SAR (PSAR)100
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- SMA 50 Cross Up100
SMA 50 Cross Up detects when faster averages cross above the 50-period SMA.
- Stochastic (14)89
Stochastic Oscillator (14-period) compares the current price to its range over 14 periods.
Holding it back
- TRIX5
TRIX is a momentum oscillator that filters out short-term noise by triple-smoothing price data.
- Bollinger Bands (20)18
Bollinger Bands (20-period) plot standard deviations above and below a moving average.
- Williams %R (7)22
Williams %R (7-period) places the close within the last 7 periods' high-low range.
61 weighted scorers; 4 had no data today and are left out rather than counted as zero.
News · shown, not counted
- Global News
- 57
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 62 | 1 |
| Daily | 62 | 3 |
| Weekly | 68 | 2 |
| Monthly | 70 | 2 |
| Quarterly | 71 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 21, 2026 | 65 |
| Oct 20, 2026 | 63 |
| Oct 19, 2026 | 61 |
| Oct 18, 2026 | 62 |
| Oct 17, 2026 | 62 |
| Oct 16, 2026 | 62 |
| Oct 15, 2026 | 63 |
| Oct 14, 2026 | 61 |
| Oct 13, 2026 | 59 |
| Oct 12, 2026 | 62 |
| Oct 11, 2026 | 62 |
| Oct 10, 2026 | 62 |
| Oct 9, 2026 | 62 |
| Oct 8, 2026 | 61 |
| Oct 7, 2026 | 62 |
| Oct 6, 2026 | 61 |
| Oct 5, 2026 | 61 |
| Oct 4, 2026 | 61 |
| Oct 3, 2026 | 61 |
| Oct 2, 2026 | 61 |
| Oct 1, 2026 | 62 |
| Sep 30, 2026 | 64 |
| Sep 29, 2026 | 65 |
| Sep 28, 2026 | 65 |
| Sep 27, 2026 | 65 |
| Sep 26, 2026 | 65 |
| Sep 25, 2026 | 66 |
| Sep 24, 2026 | 65 |
| Sep 23, 2026 | 66 |
| Sep 22, 2026 | 64 |
| Sep 21, 2026 | 63 |
| Sep 20, 2026 | 62 |
| Sep 19, 2026 | 62 |
| Sep 18, 2026 | 62 |
| Sep 17, 2026 | 63 |
| Sep 16, 2026 | 63 |
| Sep 15, 2026 | 63 |
| Sep 14, 2026 | 64 |
| Sep 13, 2026 | 63 |
| Sep 12, 2026 | 63 |
| Sep 11, 2026 | 63 |
| Sep 10, 2026 | 62 |
| Sep 9, 2026 | 69 |
| Sep 8, 2026 | 64 |
| Sep 7, 2026 | 65 |
| Sep 6, 2026 | 65 |
| Sep 5, 2026 | 65 |
| Sep 4, 2026 | 66 |
| Sep 3, 2026 | 67 |
| Sep 2, 2026 | 67 |
| Sep 1, 2026 | 66 |
| Aug 31, 2026 | 66 |
| Aug 30, 2026 | 65 |
| Aug 29, 2026 | 65 |
| Aug 28, 2026 | 65 |
| Aug 27, 2026 | 66 |
| Aug 26, 2026 | 66 |
| Aug 25, 2026 | 66 |
| Aug 24, 2026 | 66 |
| Aug 23, 2026 | 66 |
| Aug 22, 2026 | 66 |
| Aug 20, 2026 | 67 |
| Aug 19, 2026 | 67 |
| Aug 18, 2026 | 67 |
| Aug 17, 2026 | 66 |
| Aug 16, 2026 | 65 |
| Aug 15, 2026 | 65 |
| Aug 14, 2026 | 64 |
| Aug 13, 2026 | 66 |
| Aug 12, 2026 | 67 |
| Aug 11, 2026 | 67 |
| Aug 10, 2026 | 68 |
| Aug 9, 2026 | 66 |
| Aug 8, 2026 | 66 |
| Aug 7, 2026 | 66 |
| Aug 6, 2026 | 62 |
| Aug 5, 2026 | 63 |
| Aug 4, 2026 | 62 |
| Aug 3, 2026 | 61 |
| Aug 2, 2026 | 60 |
| Jul 31, 2026 | 75 |
| Jul 30, 2026 | 74 |
| Jul 29, 2026 | 75 |
| Jul 28, 2026 | 76 |
| Jul 27, 2026 | 75 |
| Jul 26, 2026 | 75 |
| Jul 25, 2026 | 75 |
| Jul 24, 2026 | 76 |
Key facts
- Market cap
- $132.9B
- Sector
- Healthcare
- Industry
- Biotechnology
- Beta
- 0.28
- Risk grade (1–10)
- 6
- Next earnings
- Nov 2, 2026
Biotechnology peers
| Company | Market cap | Score |
|---|---|---|
| MRNA Moderna | $98.1B | 51 |
| REGN Regeneron Pharmaceuticals | $82.9B | 65 |
| ARGX argenx SE | $56.0B | 66 |
| ONC BeOne Medicines AG | $44.0B | 67 |
| RVMD Revolution Medicines | $41.6B | 46 |
| RPRX Royalty Pharma | $35.9B | 60 |
Questions
What is VRTX's stock score today?
VRTX scores 65/100 (Neutral) as of Oct 21, 2026: technical 66, fundamental 63, and news sentiment 57, which is shown but not counted. Scores are recomputed every night.
Is VRTX a buy?
The score is not a buy or sell recommendation. A 65 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the VRTX score calculated?
102 weighted scorers feed it today: 41 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.